BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//GAWEL//EU and Swiss Regulatory Tracker//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:EU and Swiss regulatory milestones
X-WR-CALDESC:Dated milestones for the EU and Swiss instruments tracked at h
 ttps://gawel.ch/regulatory-tracker/ Each entry links the official text it 
 was read from.
BEGIN:VEVENT
UID:mdr-20170405-ab3cc6a2882f@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20170405
DTEND;VALUE=DATE:20170406
SUMMARY:MDR: Signed by Parliament and Council
DESCRIPTION:Medical Device Regulation (Regulation (EU) 2017/745).\nSigned b
 y Parliament and Council.\nOfficial text: https://eur-lex.europa.eu/eli/re
 g/2017/745/oj\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,medtech,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:mdr-20210526-b014051353ad@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20210526
DTEND;VALUE=DATE:20210527
SUMMARY:MDR: Date of application
DESCRIPTION:Medical Device Regulation (Regulation (EU) 2017/745).\nDate of 
 application.\nOfficial text: https://eur-lex.europa.eu/eli/reg/2020/561/oj
 \nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,medtech,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:mdr-20251216-9af0e002ede8@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20251216
DTEND;VALUE=DATE:20251217
SUMMARY:MDR: Targeted MDR/IVDR simplification proposed (COM(2025) 1023)
DESCRIPTION:Medical Device Regulation (Regulation (EU) 2017/745).\nTargeted
  MDR/IVDR simplification proposed (COM(2025) 1023).\nOfficial text: https:
 //eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:52025PC1023\nTracker: 
 https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,medtech,proposed
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:mdr-20260528-df564719edba@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20260528
DTEND;VALUE=DATE:20260529
SUMMARY:MDR: First four modules of the European database on medical devices
  (EUDAMED) mandatory (Reg (EU) 2024/1860)
DESCRIPTION:Medical Device Regulation (Regulation (EU) 2017/745).\nFirst fo
 ur modules of the European database on medical devices (EUDAMED) mandatory
  (Reg (EU) 2024/1860).\nOfficial text: https://eur-lex.europa.eu/eli/dec/2
 025/2371/oj\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,medtech,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:mdr-20271231-73f61df85b38@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:MDR: Legacy transition ends for class III and class IIb implantable
  devices\, except listed IIb implants such as screws and plates (condition
 al)
DESCRIPTION:Medical Device Regulation (Regulation (EU) 2017/745).\nLegacy t
 ransition ends for class III and class IIb implantable devices\, except li
 sted IIb implants such as screws and plates (conditional).\nOfficial text:
  https://eur-lex.europa.eu/eli/reg/2023/607/oj\nTracker: https://gawel.ch/
 regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,medtech,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:mdr-20281231-1756861ef378@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20281231
DTEND;VALUE=DATE:20290101
SUMMARY:MDR: Legacy transition ends for other class IIb\, class IIa\, Is an
 d Im devices\, and for self-declared devices that now need a notified body
  (conditional)
DESCRIPTION:Medical Device Regulation (Regulation (EU) 2017/745).\nLegacy t
 ransition ends for other class IIb\, class IIa\, Is and Im devices\, and f
 or self-declared devices that now need a notified body (conditional).\nOff
 icial text: https://eur-lex.europa.eu/eli/reg/2023/607/oj\nTracker: https:
 //gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,medtech,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:mepv-20200701-1edd7b77c534@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20200701
DTEND;VALUE=DATE:20200702
SUMMARY:MepV: Adopted by the Federal Council
DESCRIPTION:Medizinprodukteverordnung (SR 812.213).\nAdopted by the Federal
  Council.\nOfficial text: https://www.fedlex.admin.ch/eli/oc/2020/552/de\n
 Tracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,medtech,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:mepv-20210526-e5ba07a3ecd6@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20210526
DTEND;VALUE=DATE:20210527
SUMMARY:MepV: Entry into force (revised)
DESCRIPTION:Medizinprodukteverordnung (SR 812.213).\nEntry into force (revi
 sed).\nOfficial text: https://www.fedlex.admin.ch/eli/oc/2020/552/de\nTrac
 ker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,medtech,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:mepv-20231101-d29e065f37b9@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20231101
DTEND;VALUE=DATE:20231102
SUMMARY:MepV: Transition-period alignment with Reg (EU) 2023/607 in force
DESCRIPTION:Medizinprodukteverordnung (SR 812.213).\nTransition-period alig
 nment with Reg (EU) 2023/607 in force.\nOfficial text: https://www.fedlex.
 admin.ch/eli/oc/2023/576/de\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,medtech,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:bilaterale-iii-20260302-3d2f4e704a3d@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20260302
DTEND;VALUE=DATE:20260303
SUMMARY:Bilaterale III: Package signed
DESCRIPTION:Bilaterale III package (updated Mutual Recognition Agreement) (
 BBl 2026 615 (Federal Council dispatch\, Geschäft 26.023)\; signed 2 Marc
 h 2026\, ratification pending).\nPackage signed.\nOfficial text: https://w
 ww.fedlex.admin.ch/eli/fga/2026/615/de\nTracker: https://gawel.ch/regulato
 ry-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,medtech,procedural
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:bilaterale-iii-20260313-a468e6422049@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20260313
DTEND;VALUE=DATE:20260314
SUMMARY:Bilaterale III: Federal Council dispatch (Botschaft) adopted
DESCRIPTION:Bilaterale III package (updated Mutual Recognition Agreement) (
 BBl 2026 615 (Federal Council dispatch\, Geschäft 26.023)\; signed 2 Marc
 h 2026\, ratification pending).\nFederal Council dispatch (Botschaft) adop
 ted.\nOfficial text: https://www.fedlex.admin.ch/eli/fga/2026/615/de\nTrac
 ker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,medtech,proposed
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ivdr-20170405-aaf9dad6fbbd@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20170405
DTEND;VALUE=DATE:20170406
SUMMARY:IVDR: Signed by Parliament and Council
DESCRIPTION:In Vitro Diagnostic Regulation (Regulation (EU) 2017/746).\nSig
 ned by Parliament and Council.\nOfficial text: https://eur-lex.europa.eu/e
 li/reg/2017/746/oj\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,ivd,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ivdr-20220526-b1cf60681920@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20220526
DTEND;VALUE=DATE:20220527
SUMMARY:IVDR: Date of application
DESCRIPTION:In Vitro Diagnostic Regulation (Regulation (EU) 2017/746).\nDat
 e of application.\nOfficial text: https://eur-lex.europa.eu/eli/reg/2017/7
 46/oj\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,ivd,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ivdr-20250526-20f21263df50@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20250526
DTEND;VALUE=DATE:20250527
SUMMARY:IVDR: Deadline to have a quality management system (QMS) under Art.
  10(8) IVDR in place\, a condition of the extended transition
DESCRIPTION:In Vitro Diagnostic Regulation (Regulation (EU) 2017/746).\nDea
 dline to have a quality management system (QMS) under Art. 10(8) IVDR in p
 lace\, a condition of the extended transition.\nOfficial text: https://eur
 -lex.europa.eu/eli/reg/2024/1860/oj\nTracker: https://gawel.ch/regulatory-
 tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,ivd,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ivdr-20251216-4c2e9956600b@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20251216
DTEND;VALUE=DATE:20251217
SUMMARY:IVDR: Targeted MDR/IVDR simplification proposed (COM(2025) 1023)
DESCRIPTION:In Vitro Diagnostic Regulation (Regulation (EU) 2017/746).\nTar
 geted MDR/IVDR simplification proposed (COM(2025) 1023).\nOfficial text: h
 ttps://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:52025PC1023\nTrac
 ker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,ivd,proposed
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ivdr-20271231-9aaed4e8da6d@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:IVDR: Legacy transition ends for all Directive-certified devices an
 d for self-declared class D devices (conditional)
DESCRIPTION:In Vitro Diagnostic Regulation (Regulation (EU) 2017/746).\nLeg
 acy transition ends for all Directive-certified devices and for self-decla
 red class D devices (conditional).\nOfficial text: https://eur-lex.europa.
 eu/eli/reg/2024/1860/oj\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,ivd,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ivdr-20281231-ea820ce44b6d@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20281231
DTEND;VALUE=DATE:20290101
SUMMARY:IVDR: Legacy transition ends for self-declared class C devices (con
 ditional)
DESCRIPTION:In Vitro Diagnostic Regulation (Regulation (EU) 2017/746).\nLeg
 acy transition ends for self-declared class C devices (conditional).\nOffi
 cial text: https://eur-lex.europa.eu/eli/reg/2024/1860/oj\nTracker: https:
 //gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,ivd,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ivdr-20291231-2323ba25a00b@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20291231
DTEND;VALUE=DATE:20300101
SUMMARY:IVDR: Legacy transition ends for self-declared class B and sterile 
 class A devices (conditional)
DESCRIPTION:In Vitro Diagnostic Regulation (Regulation (EU) 2017/746).\nLeg
 acy transition ends for self-declared class B and sterile class A devices 
 (conditional).\nOfficial text: https://eur-lex.europa.eu/eli/reg/2024/1860
 /oj\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,ivd,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ivdr-20301231-998d3b28c3f5@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20301231
DTEND;VALUE=DATE:20310101
SUMMARY:IVDR: Health institutions must justify each in-house device by show
 ing that no equivalent device on the market meets the target patient group
 's needs (Art. 5(5)(d) IVDR\, deferred by Reg (EU) 2024/1860)
DESCRIPTION:In Vitro Diagnostic Regulation (Regulation (EU) 2017/746).\nHea
 lth institutions must justify each in-house device by showing that no equi
 valent device on the market meets the target patient group's needs (Art. 5
 (5)(d) IVDR\, deferred by Reg (EU) 2024/1860).\nOfficial text: https://eur
 -lex.europa.eu/eli/reg/2024/1860/oj\nTracker: https://gawel.ch/regulatory-
 tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,ivd,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ivdv-20220504-ccdda81e9a0d@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20220504
DTEND;VALUE=DATE:20220505
SUMMARY:IvDV: Adopted by the Federal Council
DESCRIPTION:Verordnung über In-vitro-Diagnostika (SR 812.219).\nAdopted by
  the Federal Council.\nOfficial text: https://www.fedlex.admin.ch/eli/oc/2
 022/291/de\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,ivd,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ivdv-20220526-3637873a5c95@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20220526
DTEND;VALUE=DATE:20220527
SUMMARY:IvDV: Entry into force
DESCRIPTION:Verordnung über In-vitro-Diagnostika (SR 812.219).\nEntry into
  force.\nOfficial text: https://www.fedlex.admin.ch/eli/oc/2022/291/de\nTr
 acker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,ivd,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ivdv-20250101-9a6d3ad3b582@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20250101
DTEND;VALUE=DATE:20250102
SUMMARY:IvDV: Transition-alignment amendment in force (mirrors Reg (EU) 202
 4/1860)
DESCRIPTION:Verordnung über In-vitro-Diagnostika (SR 812.219).\nTransition
 -alignment amendment in force (mirrors Reg (EU) 2024/1860).\nOfficial text
 : https://www.fedlex.admin.ch/eli/oc/2024/741/de\nTracker: https://gawel.c
 h/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,ivd,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ivdv-20301231-95406c636f19@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20301231
DTEND;VALUE=DATE:20310101
SUMMARY:IvDV: Health institutions must justify each in-house device by show
 ing that no equivalent device on the market meets the target patient group
 's needs
DESCRIPTION:Verordnung über In-vitro-Diagnostika (SR 812.219).\nHealth ins
 titutions must justify each in-house device by showing that no equivalent 
 device on the market meets the target patient group's needs.\nOfficial tex
 t: https://www.fedlex.admin.ch/eli/oc/2024/741/de\nTracker: https://gawel.
 ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,ivd,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:gdpr-20160427-3accaf906d55@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20160427
DTEND;VALUE=DATE:20160428
SUMMARY:GDPR: Signed by Parliament and Council
DESCRIPTION:General Data Protection Regulation (Regulation (EU) 2016/679).\
 nSigned by Parliament and Council.\nOfficial text: https://eur-lex.europa.
 eu/eli/reg/2016/679/oj\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,data,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:gdpr-20180525-e04271762a57@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20180525
DTEND;VALUE=DATE:20180526
SUMMARY:GDPR: Date of application
DESCRIPTION:General Data Protection Regulation (Regulation (EU) 2016/679).\
 nDate of application.\nOfficial text: https://eur-lex.europa.eu/eli/reg/20
 16/679/oj\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,data,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:gdpr-20251119-343b45fbc7ea@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20251119
DTEND;VALUE=DATE:20251120
SUMMARY:GDPR: Digital Omnibus (data) amendment proposed (COM(2025) 837)
DESCRIPTION:General Data Protection Regulation (Regulation (EU) 2016/679).\
 nDigital Omnibus (data) amendment proposed (COM(2025) 837).\nOfficial text
 : https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:52025PC0837\nT
 racker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,data,proposed
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:dsg-20200925-02fbdd16db4d@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20200925
DTEND;VALUE=DATE:20200926
SUMMARY:DSG: Adopted by Parliament (final vote)
DESCRIPTION:Datenschutzgesetz (SR 235.1).\nAdopted by Parliament (final vot
 e).\nOfficial text: https://www.fedlex.admin.ch/eli/oc/2022/491/de\nTracke
 r: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,data,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:dsg-20230901-1e9bcf2e3a39@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20230901
DTEND;VALUE=DATE:20230902
SUMMARY:DSG: Revised act in force
DESCRIPTION:Datenschutzgesetz (SR 235.1).\nRevised act in force.\nOfficial 
 text: https://www.fedlex.admin.ch/eli/oc/2022/491/de\nTracker: https://gaw
 el.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,data,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ehds-20250211-b6cac49d2cc8@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20250211
DTEND;VALUE=DATE:20250212
SUMMARY:EHDS: Signed by Parliament and Council
DESCRIPTION:European Health Data Space Regulation (Regulation (EU) 2025/327
 ).\nSigned by Parliament and Council.\nOfficial text: https://eur-lex.euro
 pa.eu/eli/reg/2025/327/oj\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,data,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ehds-20250325-75c7f687362e@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20250325
DTEND;VALUE=DATE:20250326
SUMMARY:EHDS: Entry into force
DESCRIPTION:European Health Data Space Regulation (Regulation (EU) 2025/327
 ).\nEntry into force.\nOfficial text: https://eur-lex.europa.eu/eli/reg/20
 25/327/oj\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,data,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ehds-20270326-a737b5edd33e@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20270326
DTEND;VALUE=DATE:20270327
SUMMARY:EHDS: General application\; core implementing acts due
DESCRIPTION:European Health Data Space Regulation (Regulation (EU) 2025/327
 ).\nGeneral application\; core implementing acts due.\nOfficial text: http
 s://eur-lex.europa.eu/eli/reg/2025/327/oj\nTracker: https://gawel.ch/regul
 atory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,data,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ehds-20270326-d2030fc8b329@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20270326
DTEND;VALUE=DATE:20270327
SUMMARY:EHDS: Member States name their digital health authorities\, health 
 data access bodies and national contact points\, and notify their penalty 
 rules (Art. 19\, Art. 23\, Art. 55\, Art. 75 and Art. 99 EHDS)
DESCRIPTION:European Health Data Space Regulation (Regulation (EU) 2025/327
 ).\nMember States name their digital health authorities\, health data acce
 ss bodies and national contact points\, and notify their penalty rules (Ar
 t. 19\, Art. 23\, Art. 55\, Art. 75 and Art. 99 EHDS).\nOfficial text: htt
 ps://eur-lex.europa.eu/eli/reg/2025/327/oj\nTracker: https://gawel.ch/regu
 latory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,data,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ehds-20290326-28319bc20ef5@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20290326
DTEND;VALUE=DATE:20290327
SUMMARY:EHDS: Primary-use rules apply to the first priority data categories
  (patient summaries\, electronic prescriptions and dispensations)\; second
 ary-use rules apply to most data categories
DESCRIPTION:European Health Data Space Regulation (Regulation (EU) 2025/327
 ).\nPrimary-use rules apply to the first priority data categories (patient
  summaries\, electronic prescriptions and dispensations)\; secondary-use r
 ules apply to most data categories.\nOfficial text: https://eur-lex.europa
 .eu/eli/reg/2025/327/oj\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,data,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ehds-20310326-37c0a5ccaba8@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20310326
DTEND;VALUE=DATE:20310327
SUMMARY:EHDS: Primary-use rules extend to medical imaging studies\, test re
 sults and discharge reports\; secondary-use rules extend to the remaining 
 data categories\, including genomic data
DESCRIPTION:European Health Data Space Regulation (Regulation (EU) 2025/327
 ).\nPrimary-use rules extend to medical imaging studies\, test results and
  discharge reports\; secondary-use rules extend to the remaining data cate
 gories\, including genomic data.\nOfficial text: https://eur-lex.europa.eu
 /eli/reg/2025/327/oj\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,data,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:epdg-20150619-d9552a36e8c8@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20150619
DTEND;VALUE=DATE:20150620
SUMMARY:EPDG: Adopted by Parliament (final vote)
DESCRIPTION:Bundesgesetz über das elektronische Patientendossier (SR 816.1
 ).\nAdopted by Parliament (final vote).\nOfficial text: https://www.fedlex
 .admin.ch/eli/oc/2017/203/de\nTracker: https://gawel.ch/regulatory-tracker
 /
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,data,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:epdg-20170415-161b1ba0926b@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20170415
DTEND;VALUE=DATE:20170416
SUMMARY:EPDG: Entry into force
DESCRIPTION:Bundesgesetz über das elektronische Patientendossier (SR 816.1
 ).\nEntry into force.\nOfficial text: https://www.fedlex.admin.ch/eli/oc/2
 017/203/de\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,data,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:epdg-20251105-efb2bf8dfec0@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20251105
DTEND;VALUE=DATE:20251106
SUMMARY:EPDG: Federal Council dispatch on the EGDG (total revision) adopted
DESCRIPTION:Bundesgesetz über das elektronische Patientendossier (SR 816.1
 ).\nFederal Council dispatch on the EGDG (total revision) adopted.\nOffici
 al text: https://www.fedlex.admin.ch/eli/fga/2025/3398/de\nTracker: https:
 //gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,data,proposed
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:data-act-20231213-6f56861c8e7e@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20231213
DTEND;VALUE=DATE:20231214
SUMMARY:Data Act: Signed by Parliament and Council
DESCRIPTION:Data Act (Regulation (EU) 2023/2854).\nSigned by Parliament and
  Council.\nOfficial text: https://eur-lex.europa.eu/eli/reg/2023/2854/oj\n
 Tracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,data,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:data-act-20240111-0512e7c89ff8@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20240111
DTEND;VALUE=DATE:20240112
SUMMARY:Data Act: Entry into force
DESCRIPTION:Data Act (Regulation (EU) 2023/2854).\nEntry into force.\nOffic
 ial text: https://eur-lex.europa.eu/eli/reg/2023/2854/oj\nTracker: https:/
 /gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,data,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:data-act-20250912-1e92a85d96fe@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20250912
DTEND;VALUE=DATE:20250913
SUMMARY:Data Act: Main obligations apply
DESCRIPTION:Data Act (Regulation (EU) 2023/2854).\nMain obligations apply.\
 nOfficial text: https://eur-lex.europa.eu/eli/reg/2023/2854/oj\nTracker: h
 ttps://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,data,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:data-act-20260912-34f01810fdd8@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20260912
DTEND;VALUE=DATE:20260913
SUMMARY:Data Act: Access-by-design duty for newly marketed connected produc
 ts (Art. 3(1) Data Act)
DESCRIPTION:Data Act (Regulation (EU) 2023/2854).\nAccess-by-design duty fo
 r newly marketed connected products (Art. 3(1) Data Act).\nOfficial text: 
 https://eur-lex.europa.eu/eli/reg/2023/2854/oj\nTracker: https://gawel.ch/
 regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,data,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:data-act-20270912-aad5f11895bb@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20270912
DTEND;VALUE=DATE:20270913
SUMMARY:Data Act: Unfair-terms rules extend to pre-existing long-term contr
 acts
DESCRIPTION:Data Act (Regulation (EU) 2023/2854).\nUnfair-terms rules exten
 d to pre-existing long-term contracts.\nOfficial text: https://eur-lex.eur
 opa.eu/eli/reg/2023/2854/oj\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,data,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:nis2-20221214-44219586b53a@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20221214
DTEND;VALUE=DATE:20221215
SUMMARY:NIS2: Signed by Parliament and Council
DESCRIPTION:Directive on measures for a high common level of cybersecurity 
 across the Union (Directive (EU) 2022/2555).\nSigned by Parliament and Cou
 ncil.\nOfficial text: https://eur-lex.europa.eu/eli/dir/2022/2555/oj\nTrac
 ker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,cyber,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:nis2-20241017-2ea2820b9167@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20241017
DTEND;VALUE=DATE:20241018
SUMMARY:NIS2: Member-State transposition deadline
DESCRIPTION:Directive on measures for a high common level of cybersecurity 
 across the Union (Directive (EU) 2022/2555).\nMember-State transposition d
 eadline.\nOfficial text: https://eur-lex.europa.eu/eli/dir/2022/2555/oj\nT
 racker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,cyber,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:isg-20201218-14b6d5260408@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20201218
DTEND;VALUE=DATE:20201219
SUMMARY:ISG: Adopted by Parliament (final vote)
DESCRIPTION:Informationssicherheitsgesetz (SR 128).\nAdopted by Parliament 
 (final vote).\nOfficial text: https://www.fedlex.admin.ch/eli/oc/2022/232/
 de\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,cyber,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:isg-20240101-bc9fb65de3c8@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20240101
DTEND;VALUE=DATE:20240102
SUMMARY:ISG: Entry into force (staged)
DESCRIPTION:Informationssicherheitsgesetz (SR 128).\nEntry into force (stag
 ed).\nOfficial text: https://www.fedlex.admin.ch/eli/oc/2023/650/de\nTrack
 er: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,cyber,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:isg-20250401-0c9327a3af4f@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20250401
DTEND;VALUE=DATE:20250402
SUMMARY:ISG: Reporting duty in force: critical-infrastructure operators mus
 t report cyberattacks to the Federal Office for Cybersecurity (BACS) withi
 n 24 hours of discovery
DESCRIPTION:Informationssicherheitsgesetz (SR 128).\nReporting duty in forc
 e: critical-infrastructure operators must report cyberattacks to the Feder
 al Office for Cybersecurity (BACS) within 24 hours of discovery.\nOfficial
  text: https://www.fedlex.admin.ch/eli/oc/2025/173/de\nTracker: https://ga
 wel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,cyber,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:isg-20251001-ffae385b6790@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20251001
DTEND;VALUE=DATE:20251002
SUMMARY:ISG: Reporting-duty sanctions in force
DESCRIPTION:Informationssicherheitsgesetz (SR 128).\nReporting-duty sanctio
 ns in force.\nOfficial text: https://www.fedlex.admin.ch/eli/oc/2025/173/d
 e\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,cyber,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:isg-20260925-a8254ce92227@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20260925
DTEND;VALUE=DATE:20260926
SUMMARY:ISG: Federal Council mandated a consultation draft\, due by June 20
 27\, for a separate cybersecurity act (Cybersicherheitsgesetz\, CSG)
DESCRIPTION:Informationssicherheitsgesetz (SR 128).\nFederal Council mandat
 ed a consultation draft\, due by June 2027\, for a separate cybersecurity 
 act (Cybersicherheitsgesetz\, CSG).\nOfficial text: https://www.admin.ch/d
 e/newnsb/zX9oNK8tuI-Z\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,cyber,procedural
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:cra-20241023-95eb9164dc4d@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20241023
DTEND;VALUE=DATE:20241024
SUMMARY:CRA: Signed by Parliament and Council
DESCRIPTION:Cyber Resilience Act (Regulation (EU) 2024/2847).\nSigned by Pa
 rliament and Council.\nOfficial text: https://eur-lex.europa.eu/eli/reg/20
 24/2847/oj\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,cyber,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:cra-20241210-569d24727fc8@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20241210
DTEND;VALUE=DATE:20241211
SUMMARY:CRA: Entry into force
DESCRIPTION:Cyber Resilience Act (Regulation (EU) 2024/2847).\nEntry into f
 orce.\nOfficial text: https://eur-lex.europa.eu/eli/reg/2024/2847/oj\nTrac
 ker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,cyber,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:cra-20260611-d69db488fce8@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20260611
DTEND;VALUE=DATE:20260612
SUMMARY:CRA: Notified-body framework applies (Art. 35–51 CRA)
DESCRIPTION:Cyber Resilience Act (Regulation (EU) 2024/2847).\nNotified-bod
 y framework applies (Art. 35–51 CRA).\nOfficial text: https://eur-lex.eu
 ropa.eu/eli/reg/2024/2847/oj\nTracker: https://gawel.ch/regulatory-tracker
 /
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,cyber,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:cra-20260911-8add12e68129@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20260911
DTEND;VALUE=DATE:20260912
SUMMARY:CRA: Reporting obligations (Art. 14 CRA) apply
DESCRIPTION:Cyber Resilience Act (Regulation (EU) 2024/2847).\nReporting ob
 ligations (Art. 14 CRA) apply.\nOfficial text: https://eur-lex.europa.eu/e
 li/reg/2024/2847/oj\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,cyber,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:cra-20271211-fdb42e6d890c@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20271211
DTEND;VALUE=DATE:20271212
SUMMARY:CRA: Main obligations apply
DESCRIPTION:Cyber Resilience Act (Regulation (EU) 2024/2847).\nMain obligat
 ions apply.\nOfficial text: https://eur-lex.europa.eu/eli/reg/2024/2847/oj
 \nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,cyber,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ai-act-20240613-3faad3eda381@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20240613
DTEND;VALUE=DATE:20240614
SUMMARY:AI Act: Signed by Parliament and Council
DESCRIPTION:Artificial Intelligence Act (Regulation (EU) 2024/1689).\nSigne
 d by Parliament and Council.\nOfficial text: https://eur-lex.europa.eu/eli
 /reg/2024/1689/oj\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,ai,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ai-act-20240801-1e3f0cb31b3e@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20240801
DTEND;VALUE=DATE:20240802
SUMMARY:AI Act: Entry into force
DESCRIPTION:Artificial Intelligence Act (Regulation (EU) 2024/1689).\nEntry
  into force.\nOfficial text: https://eur-lex.europa.eu/eli/reg/2024/1689/o
 j\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,ai,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ai-act-20250202-3629f7d4f124@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20250202
DTEND;VALUE=DATE:20250203
SUMMARY:AI Act: Prohibitions (Art. 5 AI Act) and AI-literacy duty (Art. 4 A
 I Act) apply
DESCRIPTION:Artificial Intelligence Act (Regulation (EU) 2024/1689).\nProhi
 bitions (Art. 5 AI Act) and AI-literacy duty (Art. 4 AI Act) apply.\nOffic
 ial text: https://eur-lex.europa.eu/eli/reg/2024/1689/oj\nTracker: https:/
 /gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,ai,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ai-act-20250802-5ad0bc2b1eb5@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20250802
DTEND;VALUE=DATE:20250803
SUMMARY:AI Act: General-purpose AI (GPAI) model obligations\, governance an
 d penalties apply
DESCRIPTION:Artificial Intelligence Act (Regulation (EU) 2024/1689).\nGener
 al-purpose AI (GPAI) model obligations\, governance and penalties apply.\n
 Official text: https://eur-lex.europa.eu/eli/reg/2024/1689/oj\nTracker: ht
 tps://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,ai,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ai-act-20260802-838511091223@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20260802
DTEND;VALUE=DATE:20260803
SUMMARY:AI Act: Transparency obligations apply (Art. 50 AI Act\; not deferr
 ed)
DESCRIPTION:Artificial Intelligence Act (Regulation (EU) 2024/1689).\nTrans
 parency obligations apply (Art. 50 AI Act\; not deferred).\nOfficial text:
  https://eur-lex.europa.eu/eli/reg/2024/1689/oj\nTracker: https://gawel.ch
 /regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,ai,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ai-act-20261202-9d77f3ec8f2c@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20261202
DTEND;VALUE=DATE:20261203
SUMMARY:AI Act: Marking grace period ends for pre-August-2026 generative sy
 stems (Art. 50(2) AI Act)
DESCRIPTION:Artificial Intelligence Act (Regulation (EU) 2024/1689).\nMarki
 ng grace period ends for pre-August-2026 generative systems (Art. 50(2) AI
  Act).\nOfficial text: https://eur-lex.europa.eu/eli/reg/2026/1744/oj\nTra
 cker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,ai,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ai-act-20261202-23ebbb0746a3@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20261202
DTEND;VALUE=DATE:20261203
SUMMARY:AI Act: Prohibitions of AI systems that generate non-consensual int
 imate imagery or child sexual abuse material apply (Art. 5(1)(ba) and (bb)
  AI Act\, inserted by Reg (EU) 2026/1744)
DESCRIPTION:Artificial Intelligence Act (Regulation (EU) 2024/1689).\nProhi
 bitions of AI systems that generate non-consensual intimate imagery or chi
 ld sexual abuse material apply (Art. 5(1)(ba) and (bb) AI Act\, inserted b
 y Reg (EU) 2026/1744).\nOfficial text: https://eur-lex.europa.eu/eli/reg/2
 026/1744/oj\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,ai,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ai-act-20270802-43dbd26dc1b4@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20270802
DTEND;VALUE=DATE:20270803
SUMMARY:AI Act: Legacy GPAI models must comply (Art. 111(3) AI Act)
DESCRIPTION:Artificial Intelligence Act (Regulation (EU) 2024/1689).\nLegac
 y GPAI models must comply (Art. 111(3) AI Act).\nOfficial text: https://eu
 r-lex.europa.eu/eli/reg/2024/1689/oj\nTracker: https://gawel.ch/regulatory
 -tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,ai,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ai-act-20271202-37bbc243ba6c@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20271202
DTEND;VALUE=DATE:20271203
SUMMARY:AI Act: High-risk obligations for Annex III AI Act systems apply (d
 eferred by Reg (EU) 2026/1744)
DESCRIPTION:Artificial Intelligence Act (Regulation (EU) 2024/1689).\nHigh-
 risk obligations for Annex III AI Act systems apply (deferred by Reg (EU) 
 2026/1744).\nOfficial text: https://eur-lex.europa.eu/eli/reg/2026/1744/oj
 \nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,ai,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ai-act-20280802-6c43a305515a@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20280802
DTEND;VALUE=DATE:20280803
SUMMARY:AI Act: High-risk obligations for Annex I AI Act product-embedded s
 ystems apply (deferred by Reg (EU) 2026/1744)
DESCRIPTION:Artificial Intelligence Act (Regulation (EU) 2024/1689).\nHigh-
 risk obligations for Annex I AI Act product-embedded systems apply (deferr
 ed by Reg (EU) 2026/1744).\nOfficial text: https://eur-lex.europa.eu/eli/r
 eg/2026/1744/oj\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,ai,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ctr-20140416-6dafdc728268@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20140416
DTEND;VALUE=DATE:20140417
SUMMARY:CTR: Signed by Parliament and Council
DESCRIPTION:Clinical Trials Regulation (Regulation (EU) No 536/2014).\nSign
 ed by Parliament and Council.\nOfficial text: https://eur-lex.europa.eu/el
 i/reg/2014/536/oj\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,clinical,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ctr-20220131-b2ba85484b8c@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20220131
DTEND;VALUE=DATE:20220201
SUMMARY:CTR: Date of application
DESCRIPTION:Clinical Trials Regulation (Regulation (EU) No 536/2014).\nDate
  of application.\nOfficial text: https://eur-lex.europa.eu/eli/dec/2021/12
 40/oj\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,clinical,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:ctr-20250131-004d66abbcc3@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20250131
DTEND;VALUE=DATE:20250201
SUMMARY:CTR: Transition complete: all ongoing trials under the CTR in the C
 linical Trials Information System (CTIS)
DESCRIPTION:Clinical Trials Regulation (Regulation (EU) No 536/2014).\nTran
 sition complete: all ongoing trials under the CTR in the Clinical Trials I
 nformation System (CTIS).\nOfficial text: https://eur-lex.europa.eu/eli/re
 g/2014/536/oj\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,clinical,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:hfg-20110930-8822a9bcbe1a@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20110930
DTEND;VALUE=DATE:20111001
SUMMARY:HFG: Adopted by Parliament (final vote)
DESCRIPTION:Humanforschungsgesetz (SR 810.30).\nAdopted by Parliament (fina
 l vote).\nOfficial text: https://www.fedlex.admin.ch/eli/oc/2013/617/de\nT
 racker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,clinical,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:hfg-20140101-bb86adf1a1aa@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20140101
DTEND;VALUE=DATE:20140102
SUMMARY:HFG: Entry into force
DESCRIPTION:Humanforschungsgesetz (SR 810.30).\nEntry into force.\nOfficial
  text: https://www.fedlex.admin.ch/eli/oc/2013/617/de\nTracker: https://ga
 wel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,clinical,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:hfg-20241101-5ddecbcf7d61@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20241101
DTEND;VALUE=DATE:20241102
SUMMARY:HFG: Revised ordinances on clinical trials (KlinV) and on human res
 earch (HFV) in force\; KlinV registration and publication rules (Art. 64
 –67 KlinV) from 1 March 2025
DESCRIPTION:Humanforschungsgesetz (SR 810.30).\nRevised ordinances on clini
 cal trials (KlinV) and on human research (HFV) in force\; KlinV registrati
 on and publication rules (Art. 64–67 KlinV) from 1 March 2025.\nOfficial
  text: https://www.fedlex.admin.ch/eli/oc/2024/322/de\nTracker: https://ga
 wel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,clinical,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:eu-pharma-package-20230426-393271c752c8@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20230426
DTEND;VALUE=DATE:20230427
SUMMARY:EU Pharma Package: Commission proposals (COM(2023) 192 Directive an
 d COM(2023) 193 Regulation)
DESCRIPTION:EU Pharmaceutical Package (Regulation and Directive) (Council f
 irst-reading positions ST-7105/26 (Regulation) and ST-7106/26 (Directive))
 .\nCommission proposals (COM(2023) 192 Directive and COM(2023) 193 Regulat
 ion).\nOfficial text: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=
 CELEX:52023PC0192\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,pharma,proposed
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:eu-pharma-package-20251211-073d7aa6b66a@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20251211
DTEND;VALUE=DATE:20251212
SUMMARY:EU Pharma Package: Provisional agreement between Council and Parlia
 ment
DESCRIPTION:EU Pharmaceutical Package (Regulation and Directive) (Council f
 irst-reading positions ST-7105/26 (Regulation) and ST-7106/26 (Directive))
 .\nProvisional agreement between Council and Parliament.\nOfficial text: h
 ttps://www.consilium.europa.eu/en/press/press-releases/2025/12/11/pharma-p
 ackage-council-and-parliament-reach-a-deal-on-new-rules-for-a-fairer-and-m
 ore-competitive-eu-pharmaceutical-sector/\nTracker: https://gawel.ch/regul
 atory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,pharma,procedural
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:eu-pharma-package-20260306-d7c7a9be69de@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20260306
DTEND;VALUE=DATE:20260307
SUMMARY:EU Pharma Package: Committee of Permanent Representatives (Coreper)
  confirmed agreement on the final compromise text
DESCRIPTION:EU Pharmaceutical Package (Regulation and Directive) (Council f
 irst-reading positions ST-7105/26 (Regulation) and ST-7106/26 (Directive))
 .\nCommittee of Permanent Representatives (Coreper) confirmed agreement on
  the final compromise text.\nOfficial text: https://data.consilium.europa.
 eu/doc/document/ST-7104-2026-INIT/en/pdf\nTracker: https://gawel.ch/regula
 tory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,pharma,procedural
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:eu-pharma-package-20260318-31cf4211ee0f@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20260318
DTEND;VALUE=DATE:20260319
SUMMARY:EU Pharma Package: Parliament's health committee (SANT) approved th
 e agreed text
DESCRIPTION:EU Pharmaceutical Package (Regulation and Directive) (Council f
 irst-reading positions ST-7105/26 (Regulation) and ST-7106/26 (Directive))
 .\nParliament's health committee (SANT) approved the agreed text.\nOfficia
 l text: https://oeil.europarl.europa.eu/oeil/en/procedure-file?reference=2
 023/0131(COD)\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,pharma,procedural
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:eu-pharma-package-20260928-42eebaa933b0@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20260928
DTEND;VALUE=DATE:20260929
SUMMARY:EU Pharma Package: Council adopted its position at first reading\; 
 Parliament's second-reading vote and publication remain pending
DESCRIPTION:EU Pharmaceutical Package (Regulation and Directive) (Council f
 irst-reading positions ST-7105/26 (Regulation) and ST-7106/26 (Directive))
 .\nCouncil adopted its position at first reading\; Parliament's second-rea
 ding vote and publication remain pending.\nOfficial text: https://data.con
 silium.europa.eu/doc/document/ST-7105-2026-REV-2-ADD-1/en/pdf\nTracker: ht
 tps://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,pharma,procedural
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:eu-pharma-package-20261123-00b4b847955c@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20261123
DTEND;VALUE=DATE:20261124
SUMMARY:EU Pharma Package: Parliament plenary vote on the agreed text (indi
 cative)
DESCRIPTION:EU Pharmaceutical Package (Regulation and Directive) (Council f
 irst-reading positions ST-7105/26 (Regulation) and ST-7106/26 (Directive))
 .\nParliament plenary vote on the agreed text (indicative).\nOfficial text
 : https://oeil.europarl.europa.eu/oeil/en/procedure-file?reference=2023/01
 31(COD)\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,pharma,procedural
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:dir-2001-83-20011106-39f139b9998b@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20011106
DTEND;VALUE=DATE:20011107
SUMMARY:Dir 2001/83/EC: Signed by Parliament and Council
DESCRIPTION:Medicinal Products Code (current) (Directive 2001/83/EC).\nSign
 ed by Parliament and Council.\nOfficial text: https://eur-lex.europa.eu/el
 i/dir/2001/83/oj\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,pharma,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:reg-726-2004-20040331-d252b2074f14@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20040331
DTEND;VALUE=DATE:20040401
SUMMARY:Reg 726/2004: Signed by Parliament and Council
DESCRIPTION:Centralized Procedure Regulation (current) (Regulation (EC) No 
 726/2004).\nSigned by Parliament and Council.\nOfficial text: https://eur-
 lex.europa.eu/eli/reg/2004/726/oj\nTracker: https://gawel.ch/regulatory-tr
 acker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,pharma,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:hmg-20001215-f8accbe9336c@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20001215
DTEND;VALUE=DATE:20001216
SUMMARY:HMG: Adopted by Parliament (final vote)
DESCRIPTION:Heilmittelgesetz (SR 812.21).\nAdopted by Parliament (final vot
 e).\nOfficial text: https://www.fedlex.admin.ch/eli/cc/2001/422/de\nTracke
 r: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,pharma,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:hmg-20250903-d226f3612e6b@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20250903
DTEND;VALUE=DATE:20250904
SUMMARY:HMG: Federal Council dispatch on revision 3a adopted
DESCRIPTION:Heilmittelgesetz (SR 812.21).\nFederal Council dispatch on revi
 sion 3a adopted.\nOfficial text: https://www.fedlex.admin.ch/eli/fga/2025/
 3017/de\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,pharma,proposed
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:hmg-20261016-cbbe51fd1932@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20261016
DTEND;VALUE=DATE:20261017
SUMMARY:HMG: Revision 3b consultation closes
DESCRIPTION:Heilmittelgesetz (SR 812.21).\nRevision 3b consultation closes.
 \nOfficial text: https://fedlex.data.admin.ch/eli/dl/proj/2026/21/cons_1\n
 Tracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,pharma,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:cma-20250311-4c5e7540fabe@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20250311
DTEND;VALUE=DATE:20250312
SUMMARY:CMA: Commission proposal
DESCRIPTION:Critical Medicines Act (COM(2025) 102 (Commission proposal)\; f
 inal compromise text ST-11059/26).\nCommission proposal.\nOfficial text: h
 ttps://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:52025PC0102\nTrac
 ker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,pharma,proposed
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:cma-20260512-01556fc24455@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20260512
DTEND;VALUE=DATE:20260513
SUMMARY:CMA: Provisional agreement between Council and Parliament
DESCRIPTION:Critical Medicines Act (COM(2025) 102 (Commission proposal)\; f
 inal compromise text ST-11059/26).\nProvisional agreement between Council 
 and Parliament.\nOfficial text: https://www.europarl.europa.eu/news/en/pre
 ss-room/20260511IPR43110/deal-on-tackling-eu-shortages-of-essential-medici
 nes\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,pharma,procedural
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:cma-20260630-93594e7a6f0a@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20260630
DTEND;VALUE=DATE:20260701
SUMMARY:CMA: Coreper endorsed the final compromise text
DESCRIPTION:Critical Medicines Act (COM(2025) 102 (Commission proposal)\; f
 inal compromise text ST-11059/26).\nCoreper endorsed the final compromise 
 text.\nOfficial text: https://data.consilium.europa.eu/doc/document/ST-110
 59-2026-INIT/en/pdf\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,pharma,procedural
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:cma-20260714-250fd415c178@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20260714
DTEND;VALUE=DATE:20260715
SUMMARY:CMA: Parliament's health committee (SANT) approved the agreed text
DESCRIPTION:Critical Medicines Act (COM(2025) 102 (Commission proposal)\; f
 inal compromise text ST-11059/26).\nParliament's health committee (SANT) a
 pproved the agreed text.\nOfficial text: https://oeil.europarl.europa.eu/o
 eil/en/procedure-file?reference=2025/0102(COD)\nTracker: https://gawel.ch/
 regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,pharma,procedural
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:cma-20261123-7b5d6b2d21d5@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20261123
DTEND;VALUE=DATE:20261124
SUMMARY:CMA: Parliament plenary vote on the agreed text (indicative)
DESCRIPTION:Critical Medicines Act (COM(2025) 102 (Commission proposal)\; f
 inal compromise text ST-11059/26).\nParliament plenary vote on the agreed 
 text (indicative).\nOfficial text: https://oeil.europarl.europa.eu/oeil/en
 /procedure-file?reference=2025/0102(COD)\nTracker: https://gawel.ch/regula
 tory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,pharma,procedural
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:lvg-20160617-bdf17b076e82@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20160617
DTEND;VALUE=DATE:20160618
SUMMARY:LVG: Adopted by Parliament (final vote)
DESCRIPTION:Landesversorgungsgesetz (SR 531).\nAdopted by Parliament (final
  vote).\nOfficial text: https://www.fedlex.admin.ch/eli/cc/2017/308/de\nTr
 acker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,pharma,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:lvg-20170601-1ac420d34599@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20170601
DTEND;VALUE=DATE:20170602
SUMMARY:LVG: Totally revised LVG in force
DESCRIPTION:Landesversorgungsgesetz (SR 531).\nTotally revised LVG in force
 .\nOfficial text: https://www.fedlex.admin.ch/eli/cc/2017/308/de\nTracker:
  https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,pharma,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:lvg-20250620-7b57a44d04c3@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20250620
DTEND;VALUE=DATE:20250621
SUMMARY:LVG: Amendment reorganizing the economic supply organization adopte
 d by Parliament (final vote)
DESCRIPTION:Landesversorgungsgesetz (SR 531).\nAmendment reorganizing the e
 conomic supply organization adopted by Parliament (final vote).\nOfficial 
 text: https://www.fedlex.admin.ch/eli/oc/2025/618/de\nTracker: https://gaw
 el.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,pharma,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:lvg-20251101-6c6c5c39e50b@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20251101
DTEND;VALUE=DATE:20251102
SUMMARY:LVG: Amendment in force
DESCRIPTION:Landesversorgungsgesetz (SR 531).\nAmendment in force.\nOfficia
 l text: https://www.fedlex.admin.ch/eli/oc/2025/618/de\nTracker: https://g
 awel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,pharma,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:gmp-chapter-4-20250707-746a79bc0727@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20250707
DTEND;VALUE=DATE:20250708
SUMMARY:GMP Ch. 4: Draft published for consultation
DESCRIPTION:EU GMP Guide Chapter 4: Documentation (EudraLex Volume 4\, Chap
 ter 4 (Documentation)).\nDraft published for consultation.\nOfficial text:
  https://health.ec.europa.eu/consultations/stakeholders-consultation-eudra
 lex-volume-4-good-manufacturing-practice-guidelines-chapter-4-annex_en\nTr
 acker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,gmp,proposed
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:gmp-chapter-4-20251007-1fec3f015a15@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20251007
DTEND;VALUE=DATE:20251008
SUMMARY:GMP Ch. 4: Consultation closed
DESCRIPTION:EU GMP Guide Chapter 4: Documentation (EudraLex Volume 4\, Chap
 ter 4 (Documentation)).\nConsultation closed.\nOfficial text: https://heal
 th.ec.europa.eu/consultations/stakeholders-consultation-eudralex-volume-4-
 good-manufacturing-practice-guidelines-chapter-4-annex_en\nTracker: https:
 //gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,gmp,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:gmp-annex-11-20250707-b29cf7804966@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20250707
DTEND;VALUE=DATE:20250708
SUMMARY:GMP Annex 11: Draft published for consultation
DESCRIPTION:EU GMP Guide Annex 11: Computerised Systems (EudraLex Volume 4\
 , Annex 11 (Computerised Systems)).\nDraft published for consultation.\nOf
 ficial text: https://health.ec.europa.eu/consultations/stakeholders-consul
 tation-eudralex-volume-4-good-manufacturing-practice-guidelines-chapter-4-
 annex_en\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,gmp,proposed
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:gmp-annex-11-20251007-88f92ef306e6@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20251007
DTEND;VALUE=DATE:20251008
SUMMARY:GMP Annex 11: Consultation closed
DESCRIPTION:EU GMP Guide Annex 11: Computerised Systems (EudraLex Volume 4\
 , Annex 11 (Computerised Systems)).\nConsultation closed.\nOfficial text: 
 https://health.ec.europa.eu/consultations/stakeholders-consultation-eudral
 ex-volume-4-good-manufacturing-practice-guidelines-chapter-4-annex_en\nTra
 cker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,gmp,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:gmp-annex-22-20250707-e06b981b91be@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20250707
DTEND;VALUE=DATE:20250708
SUMMARY:GMP Annex 22: Draft published for consultation
DESCRIPTION:EU GMP Guide Annex 22: Artificial Intelligence (EudraLex Volume
  4\, Annex 22 (Artificial Intelligence)).\nDraft published for consultatio
 n.\nOfficial text: https://health.ec.europa.eu/consultations/stakeholders-
 consultation-eudralex-volume-4-good-manufacturing-practice-guidelines-chap
 ter-4-annex_en\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,gmp,proposed
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:gmp-annex-22-20251007-6037aed86431@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20251007
DTEND;VALUE=DATE:20251008
SUMMARY:GMP Annex 22: Consultation closed
DESCRIPTION:EU GMP Guide Annex 22: Artificial Intelligence (EudraLex Volume
  4\, Annex 22 (Artificial Intelligence)).\nConsultation closed.\nOfficial 
 text: https://health.ec.europa.eu/consultations/stakeholders-consultation-
 eudralex-volume-4-good-manufacturing-practice-guidelines-chapter-4-annex_e
 n\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,gmp,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:gmp-annex-22-20260630-ae4b6ecc4af3@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20260630
DTEND;VALUE=DATE:20260701
SUMMARY:GMP Annex 22: European Medicines Agency (EMA) multistakeholder work
 shop on generative-AI scope
DESCRIPTION:EU GMP Guide Annex 22: Artificial Intelligence (EudraLex Volume
  4\, Annex 22 (Artificial Intelligence)).\nEuropean Medicines Agency (EMA)
  multistakeholder workshop on generative-AI scope.\nOfficial text: https:/
 /www.ema.europa.eu/en/events/good-manufacturing-practice-multistakeholder-
 workshop-expert-contributions-artificial-intelligence-guidance-development
 -annex-22\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,gmp,procedural
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:swiss-gmp-20181114-bb280a1fa86e@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20181114
DTEND;VALUE=DATE:20181115
SUMMARY:AMBV: Adopted by the Federal Council
DESCRIPTION:Arzneimittel-Bewilligungsverordnung (Swiss GMP / PIC/S) (AMBV (
 SR 812.212.1)\; PIC/S GMP Guide).\nAdopted by the Federal Council.\nOffici
 al text: https://www.fedlex.admin.ch/eli/cc/2018/786/de\nTracker: https://
 gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,gmp,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:pld-20241023-3f7e48d4c6ca@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20241023
DTEND;VALUE=DATE:20241024
SUMMARY:PLD: Signed by Parliament and Council
DESCRIPTION:Product Liability Directive (revised) (Directive (EU) 2024/2853
 ).\nSigned by Parliament and Council.\nOfficial text: https://eur-lex.euro
 pa.eu/eli/dir/2024/2853/oj\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,liability,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:pld-20241208-c0bbf8515486@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20241208
DTEND;VALUE=DATE:20241209
SUMMARY:PLD: Entry into force
DESCRIPTION:Product Liability Directive (revised) (Directive (EU) 2024/2853
 ).\nEntry into force.\nOfficial text: https://eur-lex.europa.eu/eli/dir/20
 24/2853/oj\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,liability,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:pld-20261209-131729da718e@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20261209
DTEND;VALUE=DATE:20261210
SUMMARY:PLD: Member-State transposition deadline
DESCRIPTION:Product Liability Directive (revised) (Directive (EU) 2024/2853
 ).\nMember-State transposition deadline.\nOfficial text: https://eur-lex.e
 uropa.eu/eli/dir/2024/2853/oj\nTracker: https://gawel.ch/regulatory-tracke
 r/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,liability,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:prhg-19930618-e5e0483c23e1@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:19930618
DTEND;VALUE=DATE:19930619
SUMMARY:PrHG: Adopted by Parliament (final vote)
DESCRIPTION:Produktehaftpflichtgesetz (SR 221.112.944).\nAdopted by Parliam
 ent (final vote).\nOfficial text: https://www.fedlex.admin.ch/eli/cc/1993/
 3122_3122_3122/de\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,liability,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:spc-eu-20090506-eef8411a1e68@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20090506
DTEND;VALUE=DATE:20090507
SUMMARY:SPC: Signed by Parliament and Council (codified version)
DESCRIPTION:Supplementary Protection Certificate (Regulation (EC) No 469/20
 09).\nSigned by Parliament and Council (codified version).\nOfficial text:
  https://eur-lex.europa.eu/eli/reg/2009/469/oj\nTracker: https://gawel.ch/
 regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,pharma,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:spc-ch-19950203-bda54f181689@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:19950203
DTEND;VALUE=DATE:19950204
SUMMARY:ESZ: SPC provisions adopted by Parliament (PatG amendment\, final v
 ote)
DESCRIPTION:Ergänzendes Schutzzertifikat (Swiss SPC) (Art. 140a ff. PatG (
 SR 232.14)).\nSPC provisions adopted by Parliament (PatG amendment\, final
  vote).\nOfficial text: https://www.fedlex.admin.ch/eli/oc/1995/2879_2879_
 2879/de\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,pharma,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:atmp-20071113-af66e5efc89b@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20071113
DTEND;VALUE=DATE:20071114
SUMMARY:ATMP Reg: Signed by Parliament and Council
DESCRIPTION:Advanced Therapy Medicinal Products Regulation (Regulation (EC)
  No 1394/2007).\nSigned by Parliament and Council.\nOfficial text: https:/
 /eur-lex.europa.eu/eli/reg/2007/1394/oj\nTracker: https://gawel.ch/regulat
 ory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,pharma,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:atmp-ch-20041008-30a2b100df76@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20041008
DTEND;VALUE=DATE:20041009
SUMMARY:TxG/HMG (ATMP): TxG adopted by Parliament (final vote)
DESCRIPTION:Transplantationsgesetz and Heilmittelgesetz (ATMP rules) (SR 81
 0.21\; SR 812.21).\nTxG adopted by Parliament (final vote).\nOfficial text
 : https://www.fedlex.admin.ch/eli/cc/2007/279/de\nTracker: https://gawel.c
 h/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,pharma,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:atmp-ch-20070701-6e44631fca50@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20070701
DTEND;VALUE=DATE:20070702
SUMMARY:TxG/HMG (ATMP): TxG entry into force
DESCRIPTION:Transplantationsgesetz and Heilmittelgesetz (ATMP rules) (SR 81
 0.21\; SR 812.21).\nTxG entry into force.\nOfficial text: https://www.fedl
 ex.admin.ch/eli/cc/2007/279/de\nTracker: https://gawel.ch/regulatory-track
 er/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,pharma,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:atmp-ch-20230929-d540bf2514c0@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20230929
DTEND;VALUE=DATE:20230930
SUMMARY:TxG/HMG (ATMP): TxG revision adopted by Parliament
DESCRIPTION:Transplantationsgesetz and Heilmittelgesetz (ATMP rules) (SR 81
 0.21\; SR 812.21).\nTxG revision adopted by Parliament.\nOfficial text: ht
 tps://www.fedlex.admin.ch/eli/fga/2023/2294/de\nTracker: https://gawel.ch/
 regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,pharma,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:soho-20240613-0d9689dd8382@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20240613
DTEND;VALUE=DATE:20240614
SUMMARY:SoHO Reg: Signed by Parliament and Council
DESCRIPTION:Substances of Human Origin Regulation (Regulation (EU) 2024/193
 8).\nSigned by Parliament and Council.\nOfficial text: https://eur-lex.eur
 opa.eu/eli/reg/2024/1938/oj\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,pharma,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:soho-20240806-53764a1dc5a2@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20240806
DTEND;VALUE=DATE:20240807
SUMMARY:SoHO Reg: Entry into force
DESCRIPTION:Substances of Human Origin Regulation (Regulation (EU) 2024/193
 8).\nEntry into force.\nOfficial text: https://eur-lex.europa.eu/eli/reg/2
 024/1938/oj\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,pharma,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:soho-20270807-9d8ea8c98530@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20270807
DTEND;VALUE=DATE:20270808
SUMMARY:SoHO Reg: Main obligations apply
DESCRIPTION:Substances of Human Origin Regulation (Regulation (EU) 2024/193
 8).\nMain obligations apply.\nOfficial text: https://eur-lex.europa.eu/eli
 /reg/2024/1938/oj\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,pharma,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:soho-20280807-8595483a08a9@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20280807
DTEND;VALUE=DATE:20280808
SUMMARY:SoHO Reg: Penalties apply\; legacy blood and tissue establishments 
 and their preparations are verified and recorded on the EU SoHO Platform
DESCRIPTION:Substances of Human Origin Regulation (Regulation (EU) 2024/193
 8).\nPenalties apply\; legacy blood and tissue establishments and their pr
 eparations are verified and recorded on the EU SoHO Platform.\nOfficial te
 xt: https://eur-lex.europa.eu/eli/reg/2024/1938/oj\nTracker: https://gawel
 .ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,pharma,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:soho-ch-20041008-e752e26ba88c@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20041008
DTEND;VALUE=DATE:20041009
SUMMARY:HMG/TxG (SoHO): TxG adopted by Parliament (final vote)
DESCRIPTION:Heilmittelgesetz and Transplantationsgesetz (SoHO coverage) (SR
  812.21\; SR 810.21).\nTxG adopted by Parliament (final vote).\nOfficial t
 ext: https://www.fedlex.admin.ch/eli/cc/2007/279/de\nTracker: https://gawe
 l.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,pharma,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:hta-20211215-60a805c31aec@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20211215
DTEND;VALUE=DATE:20211216
SUMMARY:HTA Reg: Signed by Parliament and Council
DESCRIPTION:Health Technology Assessment Regulation (Regulation (EU) 2021/2
 282).\nSigned by Parliament and Council.\nOfficial text: https://eur-lex.e
 uropa.eu/eli/reg/2021/2282/oj\nTracker: https://gawel.ch/regulatory-tracke
 r/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,pharma,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:hta-20250112-d7e9598a1053@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20250112
DTEND;VALUE=DATE:20250113
SUMMARY:HTA Reg: Application begins (oncology / ATMPs first)
DESCRIPTION:Health Technology Assessment Regulation (Regulation (EU) 2021/2
 282).\nApplication begins (oncology / ATMPs first).\nOfficial text: https:
 //eur-lex.europa.eu/eli/reg/2021/2282/oj\nTracker: https://gawel.ch/regula
 tory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,pharma,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:hta-20280113-6c34c02d7efb@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20280113
DTEND;VALUE=DATE:20280114
SUMMARY:HTA Reg: Joint clinical assessment extends to orphan medicinal prod
 ucts
DESCRIPTION:Health Technology Assessment Regulation (Regulation (EU) 2021/2
 282).\nJoint clinical assessment extends to orphan medicinal products.\nOf
 ficial text: https://eur-lex.europa.eu/eli/reg/2021/2282/oj\nTracker: http
 s://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,pharma,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:hta-20300113-23c0160782fb@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20300113
DTEND;VALUE=DATE:20300114
SUMMARY:HTA Reg: Joint clinical assessment extends to all other medicinal p
 roducts in its scope (Art. 7(2)(c) HTA Regulation)
DESCRIPTION:Health Technology Assessment Regulation (Regulation (EU) 2021/2
 282).\nJoint clinical assessment extends to all other medicinal products i
 n its scope (Art. 7(2)(c) HTA Regulation).\nOfficial text: https://eur-lex
 .europa.eu/eli/reg/2021/2282/oj\nTracker: https://gawel.ch/regulatory-trac
 ker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,pharma,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:orphan-19991216-97039a274e40@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:19991216
DTEND;VALUE=DATE:19991217
SUMMARY:Orphan Reg: Signed by Parliament and Council
DESCRIPTION:Orphan Medicinal Products Regulation (Regulation (EC) No 141/20
 00).\nSigned by Parliament and Council.\nOfficial text: https://eur-lex.eu
 ropa.eu/eli/reg/2000/141/oj\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,pharma,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:orphan-ch-20160318-3c3e6f17e862@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20160318
DTEND;VALUE=DATE:20160319
SUMMARY:HMG (Orphan): Orphan-drug provisions adopted by Parliament (HMG ame
 ndment\, final vote)
DESCRIPTION:Heilmittelgesetz orphan-drug regime (Art. 4 Abs. 1 Bst. adecies
 \, Art. 14 Abs. 1 Bst. f\, Art. 11b Abs. 4 HMG (SR 812.21)).\nOrphan-drug 
 provisions adopted by Parliament (HMG amendment\, final vote).\nOfficial t
 ext: https://www.fedlex.admin.ch/eli/oc/2017/280/de\nTracker: https://gawe
 l.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,pharma,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:orphan-ch-20190101-503eae8f2fb6@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20190101
DTEND;VALUE=DATE:20190102
SUMMARY:HMG (Orphan): Revised HMG orphan provisions in force
DESCRIPTION:Heilmittelgesetz orphan-drug regime (Art. 4 Abs. 1 Bst. adecies
 \, Art. 14 Abs. 1 Bst. f\, Art. 11b Abs. 4 HMG (SR 812.21)).\nRevised HMG 
 orphan provisions in force.\nOfficial text: https://www.fedlex.admin.ch/el
 i/oc/2018/587/de\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,pharma,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:paediatric-20061212-f9808590d612@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20061212
DTEND;VALUE=DATE:20061213
SUMMARY:Pediatric Reg: Signed by Parliament and Council
DESCRIPTION:Pediatric Medicines Regulation (Regulation (EC) No 1901/2006).\
 nSigned by Parliament and Council.\nOfficial text: https://eur-lex.europa.
 eu/eli/reg/2006/1901/oj\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:EU,pharma,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:paediatric-ch-20160318-429e58a1623c@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20160318
DTEND;VALUE=DATE:20160319
SUMMARY:HMG/PatG: Pediatric provisions adopted by Parliament (HMG and PatG 
 amendment\, final vote)
DESCRIPTION:Heilmittelgesetz and Patentgesetz pediatric provisions (Art. 54
 a ff. HMG\; Art. 140n and 140t PatG).\nPediatric provisions adopted by Par
 liament (HMG and PatG amendment\, final vote).\nOfficial text: https://www
 .fedlex.admin.ch/eli/oc/2017/280/de\nTracker: https://gawel.ch/regulatory-
 tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,pharma,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:paediatric-ch-20190101-71bb7f999f38@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20190101
DTEND;VALUE=DATE:20190102
SUMMARY:HMG/PatG: Pediatric provisions of the revised HMG and PatG in force
DESCRIPTION:Heilmittelgesetz and Patentgesetz pediatric provisions (Art. 54
 a ff. HMG\; Art. 140n and 140t PatG).\nPediatric provisions of the revised
  HMG and PatG in force.\nOfficial text: https://www.fedlex.admin.ch/eli/oc
 /2018/587/de\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,pharma,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:patg-ch-19540625-651e2e139165@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:19540625
DTEND;VALUE=DATE:19540626
SUMMARY:PatG: Adopted by Parliament (final vote)
DESCRIPTION:Patentgesetz (Patent Act) (SR 232.14\; amendment of 15 March 20
 24 (AS 2026 232)).\nAdopted by Parliament (final vote).\nOfficial text: ht
 tps://www.fedlex.admin.ch/eli/cc/1955/871_893_899/de\nTracker: https://gaw
 el.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,pharma,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:patg-ch-20240315-e63fde928fd8@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20240315
DTEND;VALUE=DATE:20240316
SUMMARY:PatG: Patent-procedure revision passed in the final vote
DESCRIPTION:Patentgesetz (Patent Act) (SR 232.14\; amendment of 15 March 20
 24 (AS 2026 232)).\nPatent-procedure revision passed in the final vote.\nO
 fficial text: https://www.fedlex.admin.ch/eli/oc/2026/232/de\nTracker: htt
 ps://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,pharma,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:patg-ch-20270101-8853a9c1bdbb@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20270101
DTEND;VALUE=DATE:20270102
SUMMARY:PatG: Revised patent-grant procedure in force
DESCRIPTION:Patentgesetz (Patent Act) (SR 232.14\; amendment of 15 March 20
 24 (AS 2026 232)).\nRevised patent-grant procedure in force.\nOfficial tex
 t: https://www.fedlex.admin.ch/eli/oc/2026/232/de\nTracker: https://gawel.
 ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,pharma,applied
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:kg-19951006-51a3e5b57a3c@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:19951006
DTEND;VALUE=DATE:19951007
SUMMARY:KG: Adopted by Parliament (final vote)
DESCRIPTION:Kartellgesetz (SR 251).\nAdopted by Parliament (final vote).\nO
 fficial text: https://www.fedlex.admin.ch/eli/cc/1996/546_546_546/de\nTrac
 ker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,competition,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:kg-20251219-92c192518960@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20251219
DTEND;VALUE=DATE:20251220
SUMMARY:KG: Merger-control revision (SIEC test: significant impediment to e
 ffective competition) passed in the final vote
DESCRIPTION:Kartellgesetz (SR 251).\nMerger-control revision (SIEC test: si
 gnificant impediment to effective competition) passed in the final vote.\n
 Official text: https://www.fedlex.admin.ch/eli/fga/2026/18/de\nTracker: ht
 tps://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,competition,enacted
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:kg-20260417-935a392b55c0@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20260417
DTEND;VALUE=DATE:20260418
SUMMARY:KG: Referendum deadline for the merger-control revision
DESCRIPTION:Kartellgesetz (SR 251).\nReferendum deadline for the merger-con
 trol revision.\nOfficial text: https://www.fedlex.admin.ch/eli/fga/2026/18
 /de\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,competition,deadline
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:kg-20260520-eedb8636dd2c@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20260520
DTEND;VALUE=DATE:20260521
SUMMARY:KG: Federal Council dispatch on the competition-authorities reform\
 , a second KG bill
DESCRIPTION:Kartellgesetz (SR 251).\nFederal Council dispatch on the compet
 ition-authorities reform\, a second KG bill.\nOfficial text: https://www.f
 edlex.admin.ch/eli/fga/2026/1594/de\nTracker: https://gawel.ch/regulatory-
 tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,competition,proposed
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:kg-20260917-48992acd2184@gawel.ch
DTSTAMP:20260924T000000Z
DTSTART;VALUE=DATE:20260917
DTEND;VALUE=DATE:20260918
SUMMARY:KG: Implementing-ordinance consultation closed
DESCRIPTION:Kartellgesetz (SR 251).\nImplementing-ordinance consultation cl
 osed.\nOfficial text: https://fedlex.data.admin.ch/eli/dl/proj/2026/12/con
 s_1\nTracker: https://gawel.ch/regulatory-tracker/
URL:https://gawel.ch/regulatory-tracker/
CATEGORIES:CH,competition,deadline
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR